Marksans Pharma Shares Gain 2% on Securing Approval to Market New Oral Solution in UK – Equitypandit
Shares of Marksans Pharma Ltd were trading in the green and 2% higher on 28 May after the company announced securing approval from the UK health regulators to market new oral solutions. In its regulatory filing, the company said that its wholly-owned subsidiary Reonchem has received the marketing authorisation from UK MHRA for Levetiracetam Relonchem…